3.415

+0.075 (+2.25%)
Range 3.380 - 3.460   (2.37%)
Open 3.370
Previous Close 3.340
Buy Price 3.420
Buy Volume 9
Sell Price 3.430
Sell Volume 11
Volume 634,486
Value -
Remark
Measurement Type Value
EPS (USD) -0.621
Trailing EPS (USD) -0.674
NAV (USD) 1.23
Cash In Hand (USD) 0.979
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 2.715
Price / Cash In Hand 3.411
Issued & Paid-up Shares 88,943,300
Treasury Shares -
Market Cap (M) 297.071
Par Value (USD) n.a.
Beta - 75 Days -0.503
R-Squared - 75 Days(%) 0.53
Beta - 500 Days 0.853
R-Squared - 500 Days(%) 6.55
ISIN Code
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 25 Jun 2021 03:22.
Data powered by

Upcoming Events

* Stock event date based on US timezone.

Earnings

Release Date 03 Aug 2021
View All Events

About APTOSE BIOSCIENCES INC

Aptose Biosciences Inc, formerly Lorus Therapeutics Inc., is a life sciences company. The Company is focused on the discovery, research and development of effective anticancer therapies with a safety profile. The Company has worked to establish a diverse anticancer product pipeline, with products in various stages of development ranging from pre-clinical to a completed Phase I clinical trial. Intellectual property portfolio supports its diverse product pipeline.

Loading Chart...